Sign in

CIK 0001785530

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823523180
Phone
+1 617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-11-05 GADICKE ANSBERT 10% owner Sale 10b5-1 −47,950 $1.22 $58K 5,959,172
2025-11-05 EVNIN LUKE Director Sale 10b5-1 −30,774 $1.22 $38K 3,822,421
2025-11-04 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −140,488 $1.22 $171K 6,007,122
2025-11-04 GADICKE ANSBERT 10% owner Sale 10b5-1 −140,488 $1.22 $171K 6,007,122
2025-11-04 EVNIN LUKE Director Sale 10b5-1 −90,164 $1.22 $110K 3,853,195
2025-11-03 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −94,063 $1.29 $121K 6,147,610
2025-11-03 GADICKE ANSBERT 10% owner Sale 10b5-1 −94,063 $1.29 $121K 6,147,610
2025-11-03 EVNIN LUKE Director Sale 10b5-1 −60,369 $1.29 $78K 3,943,359
2025-10-31 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −114,044 $1.28 $146K 6,241,673
2025-10-31 GADICKE ANSBERT 10% owner Sale 10b5-1 −114,044 $1.28 $146K 6,241,673
2025-10-31 EVNIN LUKE Director Sale 10b5-1 −73,192 $1.28 $94K 4,003,728
2025-10-30 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −86,936 $1.43 $124K 6,355,717
2025-10-30 GADICKE ANSBERT 10% owner Sale 10b5-1 −86,936 $1.43 $124K 6,355,717
2025-10-30 EVNIN LUKE Director Sale 10b5-1 −55,795 $1.43 $80K 4,076,920
2025-10-29 EVNIN LUKE Director Sale 10b5-1 −86,154 $1.55 $134K 4,132,715
2025-10-29 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −134,240 $1.55 $208K 6,442,653
2025-10-29 GADICKE ANSBERT 10% owner Sale 10b5-1 −134,240 $1.55 $208K 6,442,653
2025-10-28 EVNIN LUKE Director Sale 10b5-1 −44,327 $1.64 $73K 4,218,869
2025-10-28 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −69,068 $1.64 $113K 6,576,893
2025-10-28 GADICKE ANSBERT 10% owner Sale 10b5-1 −69,068 $1.64 $113K 6,576,893

Page 8 of 17 · 335 trades